Agios Pharmaceuticals, Inc. (AGIO) stock
AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/308% above fair value
$29.89−0.26 (-0.86%)
Close on Nov 17, 2026Market cap $1.78BP/E –Yield –
Agios Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Agios Pharmaceuticals's price to book ratio was 1.9× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.9× to 4.0×, with a median of 1.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.9× | +0.7 |
| 2025 | Dec 31, 2025 | 1.2× | +0.1 |
| 2024 | Dec 31, 2024 | 1.2× | −0.3 |
| 2023 | Dec 29, 2023 | 1.4× | −0.1 |
| 2022 | Dec 30, 2022 | 1.5× | +0.2 |
| 2021 | Dec 31, 2021 | 1.3× | −5.0 |
| 2020 | Dec 31, 2020 | 6.2× | −0.0 |
| 2019 | Dec 31, 2019 | 6.3× | +2.7 |
| 2018 | Dec 31, 2018 | 3.5× | −2.7 |
| 2017 | Dec 29, 2017 | 6.2× | +1.8 |
| 2016 | Dec 30, 2016 | 4.4× | −2.1 |
| 2015 | Dec 31, 2015 | 6.5× | −12.2 |
| 2014 | Dec 31, 2014 | 18.7× | +13.5 |
| 2013 | Dec 31, 2013 | 5.2× | – |
See a number that looks wrong?